- Nov 20th, 2015
- Brit Long
- leave a comment
- categories:
Category Name: practice updates
practice updates
FOAMED
- Nov 19th, 2015
- Courtney Cassella
- leave a comment
- categories:
Pulmonary embolism is a life-threatening entity affecting up to 900,000 individuals a year. Unfortunately, D-dimer levels increase with age decreasing the yield of the test. In order to increase the specificity safely, Douma et al. performed a retrospective analysis to derive age-adjusted D-dimer c...
practice updates
- Nov 18th, 2015
- Brit Long
- leave a comment
- categories:
FOAMED
- Nov 17th, 2015
- Erica Simon
- leave a comment
- categories:
Please see prior post here: http://www.emdocs.net/reversal-of-anticoagulation/ On October 16, 2015 the FDA granted accelerated approval of idarucizumab (Praxbind), a novel reversal agent of the direct thrombin inhibitor Dabigatran (Pradaxa), for utilization in life-threatening bleeding emergencies.1
practice updates
- Nov 16th, 2015
- Manpreet Singh
- leave a comment
- categories:
practice updates
- Nov 14th, 2015
- Brit Long
- leave a comment
- categories:
practice updates
- Nov 13th, 2015
- Salim Rezaie
- leave a comment
- categories:
clinical cases
- Nov 12th, 2015
- Stephen Alerhand
- leave a comment
- categories: